These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 23060584)
1. Surgery for atypical plexiform neurofibromas of the trunk in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin: a long-term follow-up. Friedrich RE; Gawad K; Derlin T; Zustin J; Hagel C Anticancer Res; 2012 Oct; 32(10):4547-51. PubMed ID: 23060584 [TBL] [Abstract][Full Text] [Related]
2. Atypical plexiform neurofibroma in NF1 with high standardised uptake value (SUV) in positron-emission tomography (PET) expressing podoplanin. Friedrich RE; Derlin T; Hagel C In Vivo; 2010; 24(6):871-6. PubMed ID: 21164047 [TBL] [Abstract][Full Text] [Related]
3. Clinical relevance of positron emission tomography and magnetic resonance imaging in the progression of internal plexiform neurofibroma in NF1. Mautner VF; Brenner W; Fünsterer C; Hagel C; Gawad K; Friedrich RE Anticancer Res; 2007; 27(4A):1819-22. PubMed ID: 17649778 [TBL] [Abstract][Full Text] [Related]
4. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395 [TBL] [Abstract][Full Text] [Related]
5. Expression of insulin-like growth-factor-1 receptor (IGF-1R) in peripheral nerve sheath tumors in neurofibromatosis type 1. Friedrich RE; Keiner D; Hagel C Anticancer Res; 2007; 27(4A):2085-90. PubMed ID: 17649826 [TBL] [Abstract][Full Text] [Related]
6. [18F]-Fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. Tsai LL; Drubach L; Fahey F; Irons M; Voss S; Ullrich NJ J Neurooncol; 2012 Jul; 108(3):469-75. PubMed ID: 22407214 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1. Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220 [TBL] [Abstract][Full Text] [Related]
8. Diagnostic Accuracy of PET/CT-Guided Percutaneous Biopsies for Malignant Peripheral Nerve Sheath Tumors in Neurofibromatosis Type 1 Patients. Brahmi M; Thiesse P; Ranchere D; Mognetti T; Pinson S; Renard C; Decouvelaere AV; Blay JY; Combemale P PLoS One; 2015; 10(10):e0138386. PubMed ID: 26445379 [TBL] [Abstract][Full Text] [Related]
9. Podoplanin and CD34 in peripheral nerve sheath tumours: focus on neurofibromatosis 1-associated atypical neurofibroma. Naber U; Friedrich RE; Glatzel M; Mautner VF; Hagel C J Neurooncol; 2011 Jun; 103(2):239-45. PubMed ID: 20821344 [TBL] [Abstract][Full Text] [Related]
10. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1. Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062 [TBL] [Abstract][Full Text] [Related]
11. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review. Ziadi A; Saliba I Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579 [TBL] [Abstract][Full Text] [Related]
12. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors. Salamon J; Mautner VF; Adam G; Derlin T Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104 [TBL] [Abstract][Full Text] [Related]
13. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1. Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076 [TBL] [Abstract][Full Text] [Related]
14. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST). Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095 [TBL] [Abstract][Full Text] [Related]
15. Limitations and benefits of FDG-PET/CT in NF1 patients with nerve sheath tumors: A cross-sectional/longitudinal study. Nishida Y; Ikuta K; Ito S; Urakawa H; Sakai T; Koike H; Ito K; Imagama S Cancer Sci; 2021 Mar; 112(3):1114-1122. PubMed ID: 33415792 [TBL] [Abstract][Full Text] [Related]
16. Plexiform neurofibromas. Korf BR Am J Med Genet; 1999 Mar; 89(1):31-7. PubMed ID: 10469434 [TBL] [Abstract][Full Text] [Related]
17. Giant malignant nerve sheath tumor of lumbosacral plexus with intraspinal extension in a child with neurofibromatosis type 1. Pratap A; Nepal P; Agrawal A; Singh MP; Pandey SR Pediatr Neurosurg; 2007; 43(5):410-3. PubMed ID: 17786009 [TBL] [Abstract][Full Text] [Related]
19. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene. Friedrich RE; Kluwe L; Fünsterer C; Mautner VF Anticancer Res; 2005; 25(3A):1699-702. PubMed ID: 16033085 [TBL] [Abstract][Full Text] [Related]
20. Giant malignant peripheral nerve sheath tumor of the scalp. F T; A M M A; B A de L; T C C C; R C L; G H T S B; H C Acta Neurol Taiwan; 2012 Sep; 21(3):133-5. PubMed ID: 23196734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]